US Stock MarketDetailed Quotes

LYRA Lyra Therapeutics

Watchlist
  • 0.199
  • +0.001+0.45%
Trading Nov 27 12:22 ET
13.04MMarket Cap-133P/E (TTM)

Lyra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lyra Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 204.800K--
--2024/Q3195.000K / 245.000K--
--2024/Q2598.000K / 346.200K--
--2024/Q1532.000K / 345.830K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 204.800K--
--2024/Q3195.000K / 245.000K--
--2024/Q2598.000K / 346.200K--
--2024/Q1532.000K / 345.830K--

Unlock Free Earnings Estimates

Lyra Therapeutics Earnings Reports

  • Lyra Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 12 16:30 ET

  • Lyra Therapeutics | 8-K: Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 12 16:25 ET

  • Lyra Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:29 ET

  • Lyra Therapeutics | 8-K: Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 14 16:16 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 27, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data